Suppr超能文献

hMLH1和hMSH2基因突变携带者患结直肠癌和子宫内膜癌的风险:校正确诊率。

Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: correction for ascertainment.

作者信息

Quehenberger F, Vasen H F A, van Houwelingen H C

机构信息

Department of Medical Statistics and Bioinformatics, Leiden University Medical Centre, Leiden, The Netherlands.

出版信息

J Med Genet. 2005 Jun;42(6):491-6. doi: 10.1136/jmg.2004.024299.

Abstract

BACKGROUND

Hereditary non-polyposis colorectal cancer (HNPCC) is caused by germline mutations of mismatch repair genes, usually in hMLH1 or hMSH2. All earlier studies on penetrance except one population based study were conducted in HNPCC families and did not correct for the way in which these families were ascertained.

OBJECTIVE

To obtain estimates of the risk of colorectal cancer (CRC) and endometrial cancer (EC) for carriers of disease causing mutations of the hMSH2 and hMLH1 genes.

METHODS

Families with known germline mutations of hMLH1 (n = 39) and hMSH2 (n = 45) were extracted from the Dutch HNPCC cancer registry. Ascertainment-corrected maximum likelihood estimation was carried out on a competing risks model for cancer of the colorectum and endometrium.

RESULTS

Both loci were analysed jointly as there was no significant difference in risk (p = 0.08). At age 70, colorectal cancer risk for men was 26.7% (95% confidence interval, 12.6% to 51.0%) and for women, 22.4% (10.6% to 43.8%); the risk for endometrial cancer was 31.5% (11.1% to 70.3%).

CONCLUSIONS

Current estimates of the CRC risk of mutations to the hMLH1 and hMSH2 locus should be replaced by considerably lower risks which account for the selection of the families.

摘要

背景

遗传性非息肉病性结直肠癌(HNPCC)由错配修复基因的种系突变引起,通常发生在hMLH1或hMSH2基因中。除一项基于人群的研究外,所有早期关于外显率的研究均在HNPCC家族中进行,且未对这些家族的确定方式进行校正。

目的

获得hMSH2和hMLH1基因致病突变携带者患结直肠癌(CRC)和子宫内膜癌(EC)风险的估计值。

方法

从荷兰HNPCC癌症登记处提取已知hMLH1(n = 39)和hMSH2(n = 45)种系突变的家族。对结直肠癌和子宫内膜癌的竞争风险模型进行校正确定后的最大似然估计。

结果

由于风险无显著差异(p = 0.08),对两个基因座进行联合分析。70岁时,男性患结直肠癌的风险为26.7%(95%置信区间,12.6%至51.0%),女性为22.4%(10.6%至43.8%);患子宫内膜癌的风险为31.5%(11.1%至70.3%)。

结论

目前对hMLH1和hMSH2基因座突变的结直肠癌风险估计应被更低的风险所取代,该风险考虑了家族的选择因素。

相似文献

5
Germline hMSH2 and hMLH1 gene mutations in incomplete HNPCC families.
Int J Cancer. 1997 Dec 10;73(6):831-6. doi: 10.1002/(sici)1097-0215(19971210)73:6<831::aid-ijc11>3.0.co;2-7.

引用本文的文献

1
[Gender-specific differences in the development of colorectal cancer in Lynch syndrome patients-A systematic review].
Chirurgie (Heidelb). 2024 Sep;95(9):696-708. doi: 10.1007/s00104-024-02159-x. Epub 2024 Aug 15.
2
Lynch Syndrome: From Multidisciplinary Management to Precision Prevention.
Cancers (Basel). 2024 Feb 20;16(5):849. doi: 10.3390/cancers16050849.
3
First case of endometrial cancer after yolk sac tumor in a patient with Li-Fraumeni syndrome.
BMC Womens Health. 2023 Jun 21;23(1):329. doi: 10.1186/s12905-023-02426-9.
5
Long-Term Survival of a Lynch Syndrome Patient With Eight Primary Tumors: A Case Report.
Front Oncol. 2022 May 10;12:896024. doi: 10.3389/fonc.2022.896024. eCollection 2022.
6
The role of DNA mismatch repair in immunotherapy of human cancer.
Int J Biol Sci. 2022 Apr 4;18(7):2821-2832. doi: 10.7150/ijbs.71714. eCollection 2022.
7
Immunology of Lynch Syndrome.
Curr Oncol Rep. 2021 Jun 14;23(8):96. doi: 10.1007/s11912-021-01085-z.
8
Recent advances in Lynch syndrome.
Exp Hematol Oncol. 2021 Jun 12;10(1):37. doi: 10.1186/s40164-021-00231-4.
10
Cumulative risks of colorectal cancer in Han Chinese patients with Lynch syndrome in Taiwan.
Sci Rep. 2021 Apr 26;11(1):8899. doi: 10.1038/s41598-021-88289-2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验